DGAP-News: Nanostart subsidiary MagForce receives renowned business award
(firmenpresse) - Nanostart AG / Key word(s): Miscellaneous
17.11.2010 15:09
---------------------------------------------------------------------------
- STEP award 2010 winner in the category product/technology
- Prize awarded in recognition of company's innovation and growth
potential
- 'New therapy option for patients diagnosed with brain tumors'
Frankfurt / Berlin - November 17, 2010 - Nanostart subsidiary MagForce
Nanotechnologies AG (FSE:MF6), a leader in the area of nanotechnology-based
cancer treatment, has been selected as the 2010 recipient of the STEP award
in the category 'product/technology'.
'We are honored to receive the prestigious STEP award in recognition of
MagForce's novel therapy for the treatment of brain tumors. Our innovative
therapeutic approach uses nanoparticles, which are activated through the
application of a magnetic field to produce heat within the tumor,' said Dr.
Peter Heinrich, CEO of MagForce. 'Following our recent EU approval, we are
focusing on building the commercial structures needed to launch our
Nano-Cancer(R) therapy at leading German cancer centers in early 2011. Our
transformation from a research and development company to a commercial
business also signifies a new therapy option for patients diagnosed with
brain tumors.'
'We congratulate our majority-owned portfolio company MagForce
Nanotechnologies on its achievement, particularly against such a field of
outstanding nominees,' commented Marco Beckmann, CEO of Nanostart AG. 'This
vote of confidence by the selection committee, comprised of experts from
both science and industry, underscores the promising outlook for
Nano-Cancer(R) therapy in the oncology market.'
The STEP award, initiated by Infraserv Höchst and F.A.Z. Institute along
with leading industry sponsors, was awarded for the fifth time this year.
More than 100 companies competed in this year's STEP award. Small and
mid-sized growth companies in innovative fields ranging from
pharmaceuticals, chemicals, life science, biotechnology, and nanotechnology
to medical and green technology are eligible to take part in the annual
competition.
About Nanostart:
Nanostart AG (OTCQX: NASRY), headquartered in the German financial capital
of Frankfurt, is the world's leading nanotechnology investment company,
with portfolio companies spanning the globe from Silicon Valley to
Singapore. The company provides venture capital financing for
nanotechnology companies in various growth phases with a focus on
innovation-driven industries of the future such as cleantech, life sciences
and IT/electronics. Through its subsidiary and venture capital fund in
Singapore, Nanostart is proud to be the investment partner of the
Singaporean government. For further information, please visit
www.nanostart.de.
About MagForce:
MagForce Nanotechnologies AG is a leader in the area of
nanotechnology-based cancer treatment and the first company worldwide to
receive European approval for a medical product using nanoparticles. Its
proprietary procedure, Nano-Cancer(R) therapy, enables the targeted
treatment of solid tumors through the intratumoral release of heat from
magnetic nanoparticles. The company's products, Nanotherm(R) and
NanoActivator(TM), which are the components of the therapy, received
EU-wide regulatory approval as medical devices for the treatment of brain
tumors. For further information, please visit www.magforce.com.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of
offers to purchase or subscribe to securities. There will be no public
offering of securities of Nanostart AG in conjunction with the existing
listing of its shares in the 'Entry Standard' segment of the regulated
unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This
notice does not constitute a securities prospectus. Neither this notice nor
the information contained within is intended for direct or indirect
distribution within Canada, Australia or Japan.
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestrasse 26-28
D-60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122
e-mail: presse(at)nanostart.de
17.11.2010 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Datum: 17.11.2010 - 15:09 Uhr
Sprache: Deutsch
News-ID 32651
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 195 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Nanostart subsidiary MagForce receives renowned business award"
steht unter der journalistisch-redaktionellen Verantwortung von
Nanostart AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
